Article

Hydroxychloroquine (HCQ) reverses anti-PD-1 immune murine checkpoint blockade: TCF1 as a marker in humans for COVID-19 and HCQ therapy

2020-09-30

Abstract excerpt

Coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a serious threat to global public health. Hydroxychloroquine (HCQ) and the antibiotic azithromycin (AZ) are still being used by thousands and numerous hospitals to treat COVID-19. In a related context, immunotherapy using checkpoint blockade (ICB) with antibodies such as anti-PD-1 has revoluti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 226fdcb0-9479-5e58-96ba-5c65a7a88ab4
DOI: 10.1101/2020.09.29.20193110

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest

Hydroxychloroquine (HCQ) reverses anti-PD-1 immune murine checkpoint blockade: TCF1 as a marker in humans for COVID-19 and HCQ therapyDOI 10.1101/2020.09.29.20193110Read

G-Quadruplex Mediated c-myc Specific Downregulation: A Unique Pathway of the Anticancer Action of Immunomodulator DrugsSemantic proximity Read

Clinical trial results show promise of targeting autophagy BRAF mutant melanoma.Semantic proximity Read

Hydroxychloroquine Synergizes With The PI3K Inhibitor BKM120 to Exhibit Antitumor Efficacy Independent of AutophagySemantic proximity Read

DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentationSemantic proximity Read

Hydroxychloroquine inhibits trained immunity – implications for COVID-19Semantic proximity Read

BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600-mutant Melanoma.Semantic proximity Read

A phase I study of erlotinib and hydroxychloroquine in advanced non-small-cell lung cancer.Semantic proximity Read

Lessons learned from a decade of immune checkpoint inhibition: The good, the bad, and the uglySemantic proximity Read